Lupin, Eugia recall products from US market: USFDA

Drugmakers Lupin and Aurobindo Pharma are recalling products from the American market due to manufacturing issues, as reported by the US Food and Drug Administration (USFDA). Lupin Pharmaceuticals Inc, a US-based unit of Lupin, is specifically recalling 3,552 bottles of Cefixime for Oral Suspension (USP 200 mg/5 mL) because of "failed content uniformity specifications."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QTjBwcV
via IFTTT